| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
by NK and NKT Cells1
,
* Division of Immunology, University of Cincinnati College of Medicine, Cincinnati, OH 45267;
Cincinnati Veterans Administration Medical Center, Cincinnati, OH 45220; and
Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229
Although IL-4 and IFN-
often have opposite effects and suppress each other’s production by T cells, IL-4 can stimulate IFN- production. To characterize this, we injected mice with IL-4 and quantified IFN- production with the in vivo cytokine capture assay. IL-4 induced Stat6-dependent IFN- production by NK and, to a lesser extent, NKT cells, but not conventional T cells, in 2–4 h. Increased IFN- production persisted at a constant rate for >24 h, but eventually declined, even with continuing IL-4 stimulation. This eventual decline in IFN- production was accompanied by a decrease in NK and T cell numbers. Consistent with a dominant role for NK cells in IL-4-stimulated IFN- secretion, IL-4 induction of IFN- was B and T cell-independent; suppressed by an anti-IL-2R
mAb that eliminates most NK and NKT cells; reduced in Stat4-deficient mice, which have decreased numbers of NK cells; and absent in Rag2/c-double-deficient mice, which lack T, B, and NK cells. IL-4-induced IFN- production was not affected by neutralizing IL-12p40 and was increased by neutralizing IL-2. IL-13, which signals through the type 2 IL-4R and mimics many IL-4 effects, failed to stimulate IFN- production and, in most experiments, suppressed basal IFN- production. Thus, IL-4, acting through the type 1 IL-4R, induces Stat6-dependent IFN- secretion by NK and NKT cells. This explains how IL-4 can contribute to Th1 cytokine-associated immune effector functions and suggests how IL-13 can have stronger proallergic effects than IL-4.
This article has been cited by other articles:
|
|
 |
|
  N. Thawani, M. Tam, and M. M. Stevenson STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia Haematologica, February 1, 2009; 94(2): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bessoles, F. Fouret, S. Dudal, G. S. Besra, F. Sanchez, and V. Lafont IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines J. Leukoc. Biol., July 1, 2008; 84(1): 224 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Munitz, E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg Distinct roles for IL-13 and IL-4 via IL-13 receptor {alpha}1 and the type II IL-4 receptor in asthma pathogenesis PNAS, May 20, 2008; 105(20): 7240 - 7245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Khodoun, C. Lewis, J.-Q. Yang, T. Orekov, C. Potter, T. Wynn, M. Mentink-Kane, G. K. Khurana Hershey, M. Wills-Karp, and F. D. Finkelman Differences in Expression, Affinity, and Function of Soluble (s)IL-4R{alpha} and sIL-13R{alpha}2 Suggest Opposite Effects on Allergic Responses J. Immunol., November 15, 2007; 179(10): 6429 - 6438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Ajuebor, Z. Wondimu, C. M. Hogaboam, T. Le, A. E.I. Proudfoot, and M. G. Swain CCR5 Deficiency Drives Enhanced Natural Killer Cell Trafficking to and Activation within the Liver in Murine T Cell-Mediated Hepatitis Am. J. Pathol., June 1, 2007; 170(6): 1975 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Becknell, T. L. Hughes, A. G. Freud, B. W. Blaser, J. Yu, R. Trotta, H. C. Mao, M. L. Caligiuri de Jesus, M. Alghothani, D. M. Benson Jr, et al. Hlx homeobox transcription factor negatively regulates interferon-{gamma} production in monokine-activated natural killer cells Blood, March 15, 2007; 109(6): 2481 - 2487. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
